reliability. Studies were then divided among reviewers and screened based on title and abstract to 140 determine if they met the inclusion criteria for full-text review. Criteria for inclusion were the following: 141
(1) a research question focused on self-managed abortion; and (2) published in English or Spanish, 142 inclusive of all publication years. Studies were excluded if they were not related to self-managed 143 abortion, were not peer-reviewed, did not present original research, did not include data on human 144 subjects, or presented individual clinical case results. Studies that were classified as potentially relevant at 7 this stage were then double-screened by all reviewers. Final screening was completed by three reviewers 146 (HM, SF, SH) who independently reviewed the full text of each study. 147 148
Data extraction 149
A standardized form was created to extract data in the following areas: study setting, study type and 150 methodology, characteristics of the intervention (e.g. intervention type, duration, and outcome measures 151 used), and relevant findings, including safety, effectiveness, methods, procurement, physical experience, 152 emotional experience, characteristics of those who self-managed, and reasons for pursuing a self-managed 153 abortion. In accordance with scoping review methodology, critical appraisal was not conducted (16, 17) . 154
Data extraction was completed by three reviewers (HM, SF, SH) . 155 156 157
Results 158
The literature search yielded 7,167 studies, including three studies added from additional sources. After 159 excluding duplicates and identifying studies through additional sources, 4,690 studies were screened for 160 inclusion based on title and abstract. The full text of 280 studies was assessed for eligibility, and 181 were 161 eliminated based on previously established exclusion criteria. Ninety-nine studies were included in the 162 final analysis as indicated by the PRISMA chart ( Figure 1 ). Characteristics of the included studies are 163 presented in Table 1 . The earliest included study was published in 1974, and the most recent in 2019. 164 165
Methods of self-managed abortion and their procurement 166
A total of 92 studies reported findings related to the type of methods people use to self-manage an 167 abortionsome effective, some not. Studies reported on data from 38 countries (one study reported on a 168 8 Latin American country that was anonymized). Methods reported fell into eight categories: (1) 169 plants/herbs (ingestion), (2) toxic substances (ingestion), (3) intrauterine trauma, (4) physical trauma, (5) 170 a combination of mifepristone and misoprostol (hereafter referred to as "mifepristone + misoprostol"), (6) 171 misoprostol only (7) alcohol and drug abuse, and (8) other drugs, substances and mixtures. Forty-two 172 studies reported on procurement of methods for self-managed abortionsome reported on procurement 173 of information, while others reported on procurement of the actual methods themselves. Information was 174 sourced primarily from the Internet, family and friends, informal vendors (people who are not physicians 175 or trained in medicine who sell pills or other abortifacients on the black market or outside of the formal 176 12 administering one 800mcg dose of misoprostol vaginally (85) . Another study reported details on 266 misoprostol dosage among participants with pregnancies at or beyond 24 weeks gestation, which ranged 267 from 400 to 1,200mcg almost all taken orally (88) . Another two studies reported more generally on 268 regimen, describing use of between one and eight misoprostol tablets, administered either vaginally or 269 orally(87); and another described participants taking "four misoprostol pills, two or three vaginally and 270 one or two orally"(50). Yet another study among participants who purchased misoprostol over the counter 271 at pharmacies in Bangladesh reported receiving between 800-2400mcg of misoprostol (68) . 272 273 Sources of procurement and/or information included online vendors (13, 39, 47, 50, 77, 78, 89) , telephone 274 vendors (47, 88), friends and relatives (13, 36, 47, 51, 61, 66, 78, (88) (89) (90) , accompaniment groups(89), 275
pharmacists (over the counter purchase with or without prescription) (13, 28, 36, 41, 43, 47, 51, 53, 66, 276 68, 78, 79, 90-97) , doctors or nurses (13, 28, 39, 43, 47, 51, 53, 61, 66, 78, 88, 92) , community health 277 workers(86), and informal vendors (41, 43, 47, 50, 51, 55, 61, 87, 88, 91, 98, 99) . Among those who 278 procured misoprostol over the counter at pharmacies, some studies described this as an easier, faster, and 279 often less expensive process than going to a clinic to obtain the same drug (43, 82, 93) , while others 280 found it difficult due to barriers such as needing a doctor's prescription (13, 51, 79) . 281 282
Alcohol and drug abuse 283
Twelve studies reported on alcohol and drug abuse, such as drinking a bottle of vodka (40), gin (11, 29, 284 37) , brandy or stout(44), Guinness(33, 49), Arak(31), smoking(35), or using cocaine (36), to self-manage 285 an abortion. Fifty studies reported on other methods of self-management that did not neatly fit within the above 289 categories. For example, taking Vitamin C (36) (37) (38) (39) (40) 76), chloroquine (31, 42, 54), Plan B or emergency 290 contraception (27, 35, 43, 45, 53, 95), laxatives (11, 23, 31, 35, 36, 44, 53) , misoprostol mixed with other 291 substances such as beer, plants, or injections (44, 98, 100), or unspecified drugs (11, 24, 30, 36, 38, 45, 292 46, 48, 53, 55, 57, 59, 63-65, 100-105) . Other examples included receiving hormonal injections or oral 293 contraceptives (24, 36, 51, 53, 95, 100, 103) , drinking non-herbal infusions (27, 28, 33, 36, 49) , including 294 broken glass (e.g., (58)) and blood tonics (e.g., (33)), and taking over the counter medications such as 295 paracetamol (41, 43, 49, 101) or aspirin, at times mixed with clear liquids such as 7-Up or Sprite(41). 296
Procurement varied by method, and included pharmacies or drugstores (27, 31, 63, 65, 95, 97) , elder 297 and/or unrelated women in the community(53), and informal sellers (11, 49, 101) . When describing the 298 array of methods people used to self-manage their abortion, one study reported that women preferred 299 methods that could be ingested rather than surgical methods, as the latter involved finding someone who 300 would perform the procedure and higher risk of exposure (11) . Not all studies mentioned where people 301 procured methods or information about abortion self-management. 302
303
Effectiveness of self-managed abortion 304 305
Nearly 30 studies presented data from over 15 countries on the effectiveness of self-managed abortion by 306 method. Included studies reported on effectiveness in varying ways, from the more specific "no longer 307 pregnant and no surgical intervention" (e.g.,(75)), to the less specific: "successful" (e.g.,(43)) and 308 "abortion ended satisfactorily" (e.g., (78)). Alternatively, some studies reported on effectiveness by 309 quantifying failures of self-managed abortion, rather than successesfor instance, some studies reported 310 on the occurrence of continuing pregnancy following abortion, but did not report in detail on other aspects 311 of effectiveness (e.g., (70)) In nearly all studies, authors evaluated effectiveness of the self-managed 312 abortion based on participant self-report. Thirteen studies reported on the effectiveness of self-managed 313 abortion attempts only among people presenting to health care with concerns or complications (50, 51, 54, 314 14 60, 63, 81, 82, 88, 103, 104, 106-108) . Given that all participants in these studies were only eligible for 315 inclusion in the study because of their experience of warning signs of complications or actual 316 complications that prompted their seeking of medical care, they are likely not a fair representation of 317 outcomes among the full sample of people that self-manage their abortions. These studies, rather, provide 318 information on the effectiveness of self-managed abortion among people that chose to seek health care as 319 a result of their self-managed abortion, but do not provide information about the effectiveness of self-320 managed abortion among all people who self-manage. Thus, due to the selection bias inherent in these 321 samples, we do not present effectiveness outcomes reported in these studies. 322
323
By method of self-managed abortion, eight studies reported on the effectiveness of the combined 324 medication abortion regimen, mifepristone + misoprostol (68-70, 72, 73, 75, 77, 80) ; three on misoprostol 325 only (68, 69, 86); and two on a range of other methods, such as ingestion of herbs and other substances 326 (30, 36) ( Table 2) . Several studies reported on effectiveness of more than one method (30, 36, 64), but it 327 was not always possible to separate effectiveness by methodin some instances, because the included 328 study had only been published in abstract form at the time of publication which did not allow space for 329 additional detail (e.g., (64)). Amongst the studies that provided information on effectiveness, the method 330 of self-managed abortion with the highest reported effectiveness was mifepristone + misoprostol. 331 332
Safety of self-managed abortion 333
Over thirty studies reported data on the safety of self-managed abortion in 20 countries (and one reported 334 on a dataset from over 80 countries). Several studies also made explicit mention of no occurrence of 335 adverse events, (e.g., (86)). Safety outcomes presented included signs of potential complications 336 (discharge, fever, heavy bleeding, pain, health facility visits), complications (hemorrhage, receipt of 337 antibiotics, surgical intervention), and adverse events (blood transfusion, death, hysterectomy, uterine 338 15 rupture, multi-organ system failure). Due to the selection bias (described above in the "Effectiveness" 339 section) inherent in reporting safety outcomes from studies that recruited only from patients presenting to 340 a health facility after abortion, we do not report on safety outcomes from these 13 studies here, although 341 list them in our references. Several other studies specifically reported no mortality due to self-managed 342 abortion, but no other safety details (e.g., (80)). 343
344
Signs of potential complications. Seven studies among non-hospital based samples reported on the 345 occurrence of heavy bleeding after self-managed abortion (36, 67-69, 72, 75, 94) . Heavy bleeding was 346 defined simply as "heavy bleeding" in two studies (36, 72), as "heavy, prolonged bleeding" in one 347 study(68), and as a variation of "more than 2 maxi pads per hour for >2 hours" by three(67, 69, 75), and 348
as "prolonged bleeding" in another(94). Among those who self-managed their abortions using 349 medications after receiving evidence-based guidelines on how to administer mifepristone + misoprostol, 350 or misoprostol alone, the proportion with heavy bleeding ranged from 5.2% (n=51) among women with 351 pregnancies <9 weeks gestation in the Republic of Ireland and Northern Ireland(75), up to 12.2%% 352 (n=11) of those who self-managed an abortion >12 weeks gestation in Indonesia(69). Among women who 353 purchased medication abortion pills at pharmacies in Bangladesh, 13% (n=14) experienced "heavy, 354 prolonged bleeding" (68); just as 13% (n=3) of women that self-managed an abortion of a confirmed 355 pregnancy in the United States, using a variety of methods, reported heavy bleeding(36). 356 357 Signs of infection. Four studies reported on the occurrence of fever or abnormal discharge among those 358 who self-managed an abortion (67, 68, 72, 75) . Fever was sometimes defined as >39 degrees Celsius, and 359 sometimes undefined. Discharge was at times defined as "abnormal vaginal discharge" or not mentioned. 360
Among people that self-managed an abortion using mifepristone + misoprostol provided by an online 361 telemedicine service, 1.7% (n=17) reported a fever or abnormal vaginal discharge in the Republic of 362
Ireland and Northern Ireland (75), similar to the 0.3%-2.4% in Poland that reported fever or abnormal 363 discharge(67). Among women who purchased medication abortion at pharmacies in Bangladesh, 19.6% 364 (n=22) reported a fever (68). 365
366
Pain. Three studies reported on pain as a sign of a potential complication (67, 72, 75) . All three defined 367 pain similarly as "persistent pain continuing several days after abortion" (75) or "pain that continued for 368 several days after the abortion"(72) and "did not go away"(67). All three studies were conducted among 369 participants that received medication abortion (mifepristone + misoprostol) from an online telemedicine 370 service. Among all users of medication abortion, 2.4% (n=24) in the Republic of Ireland and Northern 371
Ireland reported persistent pain (75), 5.1% of those <9 weeks gestation and 6.5% of those 9-14 weeks 372 gestation in Poland (67) reported strong pain, while among those who had a surgical intervention in 373 Brazil, 10.9% (n=7) reported pain (72). 374 375 Visited a health facility following self-managed abortion. Eight studies reported on participants seeking 376 care at a health facility following a self-managed abortion (44, 67-69, 73, 75, 78, 86) . Among women 377 along the Thailand/Burma border who self-managed with misoprostol alone, 0.3% (n=3) sought care at a 378 clinic after the absence of expected bleeding(86). Among women who were supported through self-379 managed abortion beyond the first trimester by a safe abortion hotline in Indonesia, 3% (n=3) visited a 380 health facility, all for heavy bleeding(69). A similar proportion of women who purchased medication 381 abortion pills from pharmacies in Bangladesh, 2% (n=2), visited a general practitioner at some point after 382 taking the pills (68). Among users of mifepristone + misoprostol from an online telemedicine service, 383 9.3% of users in the Republic of Ireland and Northern Ireland were advised to seek care at a health facility 384 by the web service, while 8.8% actually did visit a health facility(75). Comparatively, 3.3% of people <9 385 weeks gestation and 12.2% of people 10-14 weeks gestation visited a health facility within 0-1 days for a 386 complaint following use of a telemedicine service in Poland(67). In an analysis of data for women from 387 17 88 countries who self-managed with mifepristone + misoprostol with support from an online telemedicine 388 service, 24.9% (n=478) reported visiting a doctor or hospital for a potential complicationalthough over 389 a longer time period than in the study in Poland (73). The percentage of women who visited a doctor or 390 hospital, however, varied by region: from 16.7% in Middle East, to 29% in Latin American and 391
Caribbean regions (73). A qualitative study of university students in Chile who self-managed abortion 392 with mifepristone + misoprostol, or misoprostol alone, reported that 27 of 30 participants sought care at a 393 health facility; although many explicitly stated that it was not for fear of a complication, rather to confirm 394 completion(78). Not all studies specified whether health care was sought for medical necessity or for 395 other reasons, including seeking confirmation that the self-managed abortion had been completed. 396 397 Surgical intervention. The occurrence of surgical intervention following self-managed abortion varied 398 across studies, and by method of self-managed abortion. Among women in Poland that used mifepristone 399 + misoprostol to self-manage their abortions using support from an online telemedicine service, 12.5% of 400 those <9 weeks gestation, and 22.6% of those 10-14 weeks gestation, reported a surgical intervention 401 (vacuum aspiration or dilation and curettage)(67). In a study of women in the Republic of Ireland and 402
Northern Ireland with gestations <9 weeks that used mifepristone + misoprostol with online telemedicine 403 support, 4.5% (n=45) reported a surgical intervention(75). In one study, two percent (n=2) of women who 404 self-managed their abortion with medication beyond 12 weeks gestation had a dilation and curettage 405 procedure at a health facility (69), while a harm-reduction program in Tanzania found that 5.6% (n=3) of 406 users of misoprostol reported a Manual Vacuum Aspiration (MVA)(94). Studies on medication abortion 407 users in Brazil, and data pooled from 88 countries, found that 11-21% of those who relied on online or 408 friend support for information on how to self-manage their abortions reported a surgical intervention (70, 409 72, 73) . A study in Uruguay where most participants administered a single 800mcg dose of misoprostol 410 vaginally reported uterine evacuation for 26-40% of participants(85). A study among women in Egypt 411 that used intra-vaginal methods to self-manage their abortions found that 56% (n=5) sought care and 412 18 received a dilation and curettage procedure (31). It is not always clear whether the surgical intervention 413 was medically necessary, or whether it was instead done to guarantee / hasten the completion of the 414 abortion. For instance, in Brazil, 40% of those that reported a surgical intervention had no signs or 415 symptoms of a complication (72). 416 417 Adverse events. Studies defined adverse events differently, including a range of events that necessitated 418 both minor and major health interventions, as well as death. Of four studies reporting on antibiotic 419 administration following abortion, estimates were 1.3% (n=5) of women who self-managed an abortion at 420 <9 weeks gestation with medications from an online telemedicine service across 88 countries(70), 2.6% 421 (n=26) of women who self-managed an abortion at <10 weeks gestation with medications from an online 422 telemedicine service in the Republic of Ireland and Northern Ireland(75), 8.1% (n=24) of women at 7-9 423 weeks gestation and 13.7% (n=17) among women 10-14 weeks gestation who self-managed with 424 medications with support from a telemedicine service in Poland (67), and 56% (n=5) of women who 425 inserted objects into the vagina and cervix in Egypt (31). Five studies reported blood transfusions among 426 participants: 0.7% (95%CI: 0.3-1.5%) of 1,000 women who self-managed an abortion with medications 427 from an online telemedicine service in the Republic of Ireland and Northern Ireland (75), 0.9% of 109 428 women who purchased medication abortion pills at pharmacies in Bangladesh (68), none among women 429 <9 weeks gestation, and 1.6% among women 10-14 weeks gestation who self-managed their abortions 430 with support from a telemedicine service in Poland (67), approximately 4% (n=2) of women in Saudi 431
Arabia who self-managed with misoprostol(92), and 4.3% of 23 women who self-induced an abortion and 432 had a confirmed pregnancy in the United States (36). Two studies reported a hysterectomy following a 433 self-managed abortion attempt, 4% (n=2) of women in Saudi Arabia who self-managed with 434 misoprostol(92), and one person who utilized a uterine probe combined with misoprostol in a population 435 of female sex workers in Brazil (87). Only one study reported on the incidence of ectopic pregnancy, 436 finding that 0.3% of 918 women receiving misoprostol up to 9 weeks gestation along the Thailand/Burma 437 19 border had an ectopic pregnancy -all of which were treated with standard clinical protocols (86). Five 438 studies reported on deaths due to self-managed abortion (24, 49, 55, 58, 103) . Deaths reported occurred 439 among women who drank "potion" or other oral preparations (n=3), including broken glass (24, 49, 55, 440 58), ingested herbs (n=5) (103), or inserted foreign bodies (n=6) (24). 441
442
Considerations by gestational age. Three studies compared safety of medication abortion outcomes by 443 gestational age (67, 72, 75) . Gomperts et al 2014 found no difference in the incidence of potential 444 complications (pain, bleeding, and fever) by gestational age among people who self-managed an abortion 445 with mifepristone + misoprostol in Brazil. Comparing outcomes across pregnancies at <9 weeks 446 gestation, 10-12 weeks gestation, and 13+ weeks gestations, the study reported the following proportions 447 across gestational age groups (in gestational age category order as listed above) by outcome: continuing 448 pain (12.5%, 9.1%, 7.7%, p=0.88); heavy bleeding (15%, 0%, 15.3%, p=0.44); and fever/vaginal 449 discharge (2.5%, 9.1%, 0%, p=0.43). Similarly, in both unadjusted and adjusted logistic regression 450 analyses of outcomes following self-managed abortions with mifepristone + misoprostol with support 451 from an online telemedicine service in Poland, there was no difference in the reported heavy-bleeding 452 following abortion between those who were <9 weeks gestation, versus 10-14 weeks gestation (aOR:1.65, 453 95%CI: 0.90, 3.04)(67). However, a study in the Republic of Ireland and Northern Ireland did find a 454 difference in reported warning signs of complications (heavy bleeding, fever/vaginal discharge, persistent 455 pain) when looking more closely at earlier gestations: a higher proportion of those at 7-9 weeks of 456 gestation reported signs of potential complications than those at <7 weeks gestation (<7 weeks: 8.1% 457 (6.2-10.2); 7-9 weeks: 13.7% (9.4-19.0), p=0.02) (75). 458
459
Beyond warning signs of complications, health care seeking and interventions received following 460 abortion may increase with gestational age. The above study from Poland found that hospital visits 461 20 resulting from a complaint in the 0-1 days following the abortion (aOR: 3.82, 95%CI: 1.9, 7.7), as well as 462 surgical intervention (aOR: 2.04, 95%CI: 1.2, 3.3), as well as any treatment overall (defined as receiving 463 antibiotics or misoprostol treatment, fluid or blood transfusion, vacuum aspiration or D&C) (aOR: 1.84, 464 95%CI: 1.1, 3.0), had a higher odds among those who self-managed an abortion between 10-14 weeks 465 gestation as compared to those who self-managed at <9 weeks gestation(67). Similarly, a study among 466
Brazilian users of an online telemedicine service found that the proportion of people reporting surgical 467 intervention increased with gestational age: 19.3% of those <9 weeks, 15.5% of those 10-12 weeks, and 468 44.8% of those >13 weeks (p=0.006)(72). A similar pattern of increasing surgical intervention with 469 gestational age was reported among users of mifepristone + misoprostol in the Republic of Ireland and 470
Northern Ireland, where 3.7% (n=29) of abortions <7 weeks' gestation reported a D&E or MVA, versus 471 7.3% (n=16) of abortions 7-9 weeks' gestation (p value=0.04)(75). However, this same study found no 472 difference in self-reported treatment for adverse events (antibiotics, blood transfusion, death) among 473 women who self-managed with mifepristone + misoprostol (<7 weeks gestation: 2.7% (1.7-4.1); 7-9 474 weeks: 4.6% (2.2-8.2), p=0.19). The differences in gestational age groups compared across studies is 475 worth noting. 476 477
Characteristics of people who self-managed abortions 478
Approximately sixty studies contained demographic information about people who self-managed an 479 abortion (S1: Table 3 ). The most frequently collected demographic data included age, previous 480 pregnancies or children, educational status, relationship status, and gestational age at the time of abortion. 481
Less commonly measured demographic characteristics included employment status, socio-economic 482 status, geographic location, religion, a prior self-managed abortion attempt, knowing someone who had 483 taken misoprostol before, and knowledge of or use of contraception. Due to variation across studies in the 484 content and format of demographic data collected, we are not able to report on patterns in characteristics 485 of people who self-managed an abortion. Several studies did not report separate demographic data for 486 21 their study population if it included both people who did and did not self-manage, making it difficult to 487 report on this information. 488
489
Reasons for abortion self-management 490
Slightly over one-third of studies shared information related to people's reasons for self-managing an 491 abortion (S2: Table 4 ). Some studies did not separate out reasons participants chose to self-manage an 492 abortion from reasons a participant sought any form of abortion. Studies documented reasons for abortion 493 including financial concerns (33, 37, 43, 46, 49, 55, 57, 64, 74, 88-90, 109, 110) , a desire to continue 494 school or other life plans (33, 45, 49, 59, (88) (89) (90) 111) , not desiring any or additional children (59, 63, 74, 495 81, 89, 90, 110) , and lack of support from a partner (46, 62, 89, 90) . 496
497
Other studies documented specific barriers to clinical care that led people to pursue or consider a self-498 managed abortion (e.g., (112)). Most commonly cited barriers were logistical difficulties, including 499 traveling long distances to a clinic, taking time away from work, or arranging travel or childcare (10, 37, 500 39, 40, 46, 74, 76, 113) . Inability to pay for an in-clinic abortion (37, 46, 65, 82, 109, 112) and 501 insurmountable legal restrictions on abortion (10, 12, 23, 36, 37, 40, 45-47, 74, 89, 91, 92, 114 ) 502 contributed to people pursuing self-managed abortion. While 15 studies explicitly named legal restrictions 503 as a reason for pursuing abortion self-management, it is possible that this finding is implicit in additional 504 studies conducted in contexts where abortion is legally restricted or inaccessible. Less commonly cited 505 barriers to clinical care included physician refusal to perform an in-clinic abortion (53, 88, 92, 114) , 506 overly long wait-times for appointments (53, 88) , and lack of knowledge about where to obtain a legal 507 abortion (44-46). 508 509 22 Some studies described concerns that led people to pursue self-managed abortion, including concerns 510 about privacy and confidentiality (10, 37, 40, 42-45, 53, 58, 76, 78, 82, 84, 93, 114) , and about clinic 511 staff, including mistreatment or being reported to police (23, 40, 43, 44, 47, 50, 51, 53, 109, 111, 114) . 512
Ten studies explicitly stated that respondents pursued self-managed abortion as a way to cope with 513 abortion stigma (23, 40, 43, 45, 46, 74, 76, 84, 111, 113) or to bypass the stigma of being seen at an 514 abortion clinic (37, 43, 58) . Five studies noted that people were concerned about presenting at a clinic due 515 to the threat of violence from a partner or other person (40, 46, 62, 76, 89) . 516
517
Other studies cited proactive, positive reasons that a person might prefer self-managed abortion over 518 clinical care. In ten studies, respondents noted that the ease of using and procuring abortion pills 519 contributed to seeking a self-managed abortion (10, 13, 40, 74, 79, 82, 92, 102, 110, 115) . Other studies 520 indicated that knowing someone who had prior experience with successful self-managed abortion led 521 participants to pursue the same option (92, 114), while others highlighted the perception that self-522 managed abortion is safer or more acceptable than a surgical abortion (10, 11, 73), and still others 523 emphasized the comfort, privacy, and autonomy conferred by the self-managed nature of their abortion 524 (10-13, 37, 40, 43, 53, 61, 74, 76, 102) . Other reasons for pursuing self-management included: explicitly 525 not wanting a surgical abortion (93), being able to have someone with them during the abortion (11, 13, 526 43, 78), a previous successful self-managed abortion (115), and the perception that self-managed abortion 527 is more affordable than a facility-based, often surgical, abortion (37, 42, 64, 93) or that self-managed 528 abortion is not even abortion, rather, it is bringing on a miscarriage(93). 529 530 Physical experience of self-managed abortion 531 532
Ten studies documented physical symptoms associated with self-managed abortion by medication (13, 43, 533 51, 63, 67-69, 78, 87, 109) . All of these studies described abortion symptoms, including heavy bleeding, 534 23 cramping, and back pain, of varying intensity. Seven studies mentioned other common symptoms, 535 including nausea, dizziness, and fevers (13, 43, 63, (67) (68) (69) 109) . Symptoms reported included buzzing in 536 ears, chills, diarrhea, and expelling blood clots or the actual gestational sac (13, 78) . Four of the ten 537 studies reported on pain management techniques, including over-the-counter pain medication (13, 43, 69, 538 78) and accompaniment during the abortion (78). An eleventh study described symptoms of mild 539 cramping and diarrhea, but did not specify the method of self-managed abortion(36), and a twelfth study 540 among people contacting a poison control center after using herbal methods and other substances to self-541 manage abortion reported gastrointestinal symptoms, including abdominal pain and vomiting (103). 542 543
Emotional experiences of self-managed abortion 544
Nearly half of included studies documented emotional experiences with self-managed abortion (S3: Table  545 5). We categorized an experience as "emotional" if it documented anything related to how a person felt 546 before, during, or after the self-managed abortion. 547 548 Several studies documented respondents reporting positive emotions following self-managed abortion, 549
including gratefulness (12, 70, 74, 110) and relief (13, 74, 77) . Six studies documented participants taking 550 comfort in being able to have an abortion at home (13, 37, 40, 74, 78, 79) . Five studies documented 551 participants receiving emotional support from a partner, friend, or family member during their abortion at 552 home (13, 43, 74, 78, 89) . While they did not explicitly document positive emotions, two studies reported 553 that participants would recommend self-management to others (74, 94) . Some participants reported 554 feeling safe self-managing (76, 110) and confident that it was the right decision for them (13, 74) , 555
although it is unclear if this refers to the decision to have an abortion or the decision to self-manage. Five 556 studies documented satisfaction data related to self-managed abortion procured via an online telemedicine 557 service, finding that people were satisfied with the experience, that they "valued the privacy, 558 24 confidentiality and convenience" conferred by the telemedicine model(12), had "acceptable" levels of 559 stress, or had no specific feelings about the experience (12, 70, 72, 73, 80) . 560 561 Negative emotional experiences fell generally into two categories: a negative experience related to the 562 abortion itself or related to the environment in which the abortion occurred. Five studies explicitly named 563 guilt, sadness, stress, and/or shame (13, 65, 80, 109, 116) as emotions accompanying the self-managed 564 abortion experience. Eight studies reported fear as a powerful emotion participants experienced related to 565 self-management, including fears related to safety, death, and lack of information about how to self-566 manage an abortion effectively, or what was considered "normal" in terms of bleeding and pain (13, 31, 567 36, 47, 51, 78, 79, 99) . Two studies stated that secrecy surrounding self-managed abortion was associated 568 with concerns about safety (51, 87) . Three studies of satisfaction with telemedicine services found that a 569 small minority of people reported "extreme stress" or dissatisfaction with the self-managed abortion 570 experience (67, 70, 73) . 571
572
Studies also reported on negative emotional experiences related to the environment in which self-573 managed abortions occurred. Six studies documented fears related to legal consequences of self-managed 574 abortion, including fears of being reported to the police by health professionals (10, 40, 51, 78, 110, 114) . 575
Six studies also documented a fear of or past experiences with abortion-related mistreatment at a 576 healthcare facility (47, 50, 51, 83, 87, 114) . Five studies named stigma-related fears, including 577 community condemnation, mistreatment by peers, and an internalized sense of shame (40, 51, 109, 111, 578 113) . Three studies documented respondents expressing frustration, anger, and disappointment related to 579 having to pursue self-managed abortion as a result of the legal restrictions (40, 74) . This paper provides a comprehensive review of the existing public health literature on self-managed 583 abortion. Our findings document a wide variety of methods for self-managed abortion, and how each is 584 procured/performed. This review also describes what is known about those who self-manage their own 585 abortions, reasons for pursuing self-managed abortion, safety and effectiveness of self-managed abortion, 586 and physical and emotional experiences during the process. 587
588
The most commonly reported finding among studies in this review was the method used to self-manage 589 abortion. This may be reflective of the relative simplicity of asking people what they used to self-manage 590 an abortion, in comparison to asking about more nuanced and complex aspects of the process such as their 591 physical or emotional experiences. Additionally, the prevention of unsafe abortion has been an important 592 focus of research on abortion in highly restrictive settings-measuring and reporting on methods of self-593 managed abortion is central to that goal. 594
595
The reasons people cited for self-managed abortion often mirrored reasons that people cite for having 596 clinic-based abortion that have been previously identified in the literature (117-120). Yet, several reasons 597 unique to self-managed abortion emerged, including concerns about legal, emotional, and social safety of 598 seeking clinical care and an inability to overcome logistical and financial obstacles to clinical care. We 599 also identified a proactive preference for self-management in some studies because of its inherent privacy, 600 perceptions about the safety and ease of self-management, and knowing others who had self-managed. 601
More research is needed to understand for whom self-management is a last resort, and for whom self-602 management is a preferred method of abortion, and what interventions are needed to ensure that these 603 individuals can obtain the type of abortion they desire. 604 605 26 Despite much focus in recent years on self-management of abortion with medications, a substantial 606 proportion of studies that reported method of self-managed abortion (42 versus 61) reported on the 607 ingestion of plants and herbs as the method of abortion, as compared to describing the use of mifepristone 608 + misoprostol, or misoprostol alone. This is true even when considering articles published since the year 609 2000, after which the proportion that focused on plants and herbs remains substantial. Yet, these studies 610 on plant-based and herbal methods focused primarily on sourcing and preparation, rather than safety and 611 effectiveness; peer-reviewed, published data on these aspects of plants and herbs as abortifacients are 612 lacking. Also needed is a broader understanding of preferences for herbal or "natural" methods of self-613 managed abortion and the significance that these methods hold for many communities. Future research 614 should elevate the knowledge and experiences of communities that practice these methods, particularly 615 those that have been excluded from or mistreated by Western medicine through experiences of systemic 616 and individual-level discrimination, including but not limited to racism and sexism, which can lead to a 617 subpar standard of care for specific groups, particularly in sexual and reproductive health settings (e.g., 618
(121)). The frequent use of herbal and plant-based methods may also highlight a need to expand access to 619 and information about medication abortion, but medication abortion should not be presumed to be the 620 preferred method of choice for all people interested in self-managing an abortion. Notably, plants and 621 herbs were reported to be obtained from local herbalists, healers, friends, and family, while medication 622 abortion pills were more often obtained from the Internet, local vendors, as well as friends and family. 623 This is consistent with an understanding that the Internet can facilitate access to WHO recommended 624 methods of abortion, and also consistent with evidence that social networks play a key role in abortion 625 access, regardless of method (44, 122) . 626 627 Almost every study that described methods and procurement for self-management discussed harmful 628 methods of abortion induction. Common reports of physical trauma or toxic substance ingestion, confirm 629 previous findings that people are willing to risk their health and lives to prevent an unwanted birth and/or 630 27 parenthood (e.g., (36)), and that these more harmful methods are still very much present around the world 631 today, despite the existence of safer methods and legal access to abortion in some settings. 632
633
Beyond the presentation of methods used for self-management, many studies reported on the 634 effectiveness of self-managed abortion in its various forms. Definitions of effectiveness varied and 635
included clinical definitions such as complete uterine evacuation without additional intervention (e.g., 636
surgical evacuation), to more general definitions such as the state of no longer being pregnant. Among 637 studies reporting on self-managed medication abortion (with misoprostol alone, or in combination with 638 mifepristone), high-levels of effectiveness were reported. These studies defined effectiveness with some 639 variation, and included participants at a wide range of gestational ages. Yet, eight out of nine studies on 640 self-managed abortion with WHO-endorsed medications reported an effectiveness greater than 70% -641 with most in the mid-to-high 90s. However, due to the variation in definitions of effectiveness and the 642 wide range of methods of self-managed abortion that are presented in the included studies, an overall 643 assessment of the effectiveness of the complete range of methods of self-managed abortion was not 644 possiblenor appropriate. 645
646
The safety of self-managed abortion in the included studies was also assessed in a variety of ways, and 647 was reported in differential detail. Major adverse events were rare, although varied by method used. 648
Complications and signs of potential complications were reported and defined with different degrees of 649 detail across included studies. Of note, some studies framed health-care seeking following abortion as 650 indication of a safety concern, some with more nuance (e.g.,(67)), others with less. There are a range of 651 reasons that people may seek health care during or following an abortion, including seeking reassurance 652 about the process, obtaining confirmation of abortion completeness, or due to warning signs of a potential 653 complication. Studies that classify all health facility visits related to an abortion as "complications" likely 654 28 overestimate the proportion of self-managed abortions that result in complication and may contribute to 655 concerns about the safety of self-managed abortion (123, 124) . 656 657 Across the included studies, a range of characteristics of people who self-managed their abortions were 658 reported. In reflecting on this compiled body of self-managed abortion research, we propose that experts 659 convene to recommend the relevant demographic characteristics that would be most critical for future 660 research on self-managed abortion, and share tools for measurement. Consistency across this set of 661 informative indicators would contribute greatly to our knowledge about the people that pursue self-662 managed abortion, thereby facilitating the design of unique interventions and outreach to meet their 663 needs. Additional measures of abortion knowledge, attitudes, and stigma may be relevant to better 664 understand the relationship between self-management and these factors. 665
666
As with all research, this systematic scoping review has limitations. The search strategy we used was 667 designed to identify and review studies of self-managed abortion. Yet, we must acknowledge that in many 668 legally restrictive contexts, the majority of abortions taking place may well be self-managed abortions, 669 but are not described as suchand as a result, may have been missed by our search strategy. Further, due 670 to the nature of the databases searched, the studies we identified and included may be more likely to 671 include findings from the biomedical model as opposed to anthropological or other disciplines. With 672 regard to methodology, we restricted our search to publications in English and Spanish languages based 673 on investigators' language ability, making it likely that we missed relevant research on this topic in other 674 languages. Future research should explore the same or a similar search strategy in additional languages. 675
Further, consistent with scoping review methodology, as our aim was not to conduct a meta-analysis for a 676 particular quantitative research question about self-managed abortion, we do not evaluate the quality of 677 included studies or assess bias. Finally, due to variance in how self-managed abortion is described and 678 defined, and how that has changed over time and across disciplines, it is likely that our search strategy 679 29 may have missed key studies that present relevant results. Hand searches of known journals attempted to 680 mitigate this possibility, as did consultations with experts in the field, but it remains a near certainty that 681 some studies were missed. The limitations of this review, however, are tempered by several key strengths, 682
including the multidisciplinary nature of our research team, the rigorous and comprehensive multi-683 database search strategy that was utilized, and the iterative process of review of identified studies to 684 ensure a consistent and replicable study selection process. 685
686
In reflecting on the state of the literature presented in this review, four key areas stand out where more 687 and better evidence on self-managed abortion is urgently needed: 688  Consistency in definitions of and measurement approaches to the safety and effectiveness of, 689 and complications experienced from, methods of self-managed abortion, including non-690 medication based methods. These data would continue to advance understanding of the safety 691 of self-managed abortion with medications, would contribute to the development of global 692 guidelines, and would help individuals to understand and evaluate their choice of method. 693  More evidence on the physical experiences of self-managed abortion--including timing and 694 duration of bleeding/cramping/other side effects, pain experienced, and pain management 695 approaches. These data would help those seeking abortion to better understand the options 696 available to them, and what to expect during a "normal" abortion processperhaps 697 preventing unnecessary health facility visits. 698  Research that documents the social and emotional experience of self-managed abortion, 699 distinct from satisfaction data. Such data would contribute to a more nuanced understanding We provide a comprehensive synthesis of the scientific, peer-reviewed, public-health literature on self-711 managed abortion globally. While discussions of self-managed abortion often focus on medication 712 abortion, we found a comparable number of studies that reported on non-medication based methods, 713
including ingesting plants/herbs, toxic substances, intrauterine trauma, physical trauma, alcohol and drug 714 abuse, and more. Reported safety outcomes included signs of complications, rare actual complications, 715 and, even more rarely, adverse events. Studies reporting on self-managed medication abortion (with 716 misoprostol alone, or in combination with mifepristone) reported high-levels of effectiveness. Due to the 717 variation in definitions of effectiveness and the wide range of methods of self-managed abortion 718 presented in the included studies, an overall assessment of the effectiveness of the complete range of 719 methods of self-managed abortion was not possible. In reviewing the reasons people gave for seeking 720 self-managed abortion, many similarities existed with reasons people have given in the literature for 721 seeking clinic-based abortion care; however, reasons unique to self-managed abortion, such as a desire for 722 privacy or to avoid anticipated negative treatment by health professionals, were also common. The 723 literature on the emotional experience of self-management indicates that people feel a range of conflicting 724 emotions, including gratefulness, relief, comfort, and fearyet, more research is needed to understand 725 how people manage these emotions and others before, during, and after abortion self-management. We 726 identify gaps in the literature, particularly around a need to measure the safety and effectiveness of non-727 medication based methods of abortion self-management, and to better understand reasons for self-728 managed abortion. 729
Research Agenda 730
 Evaluate the effectiveness and safety of methods of self-managed abortion beyond 731 mifepristone and misoprostol. 732  Document the physical experiences of self-managed abortion, including timing and duration 733 of bleeding/cramping/other side effects 734 32  Document pain management techniques used before and during self-managed abortion 735  Measure the range of emotions felt about self-managed abortion, distinct from satisfaction 736 data 737  Disentangle reasons for versus preferences for self-managed abortion 738  Document pathways to self-managed abortion 739  Measure experiences with the formal healthcare system after self-managed abortion 740 741 Practice Points 742  People self-manage their own abortions for a variety of reasons, from preference for the privacy 743 inherent in this model, to viewing this mode of abortion as a last resort. 744  People use a wide variety of methods to self-manage abortion, from herbal to medication to 745 substance abuse to intrauterine trauma. 746  Data suggest that self-management of abortion with medication (mifepristone + misoprostol, or 747 misoprostol alone) is highly effective and safe. 748  Data are lacking on the safety or effectiveness of non-medication methods 749 750 Acknowledgements 751
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